• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三重重复疾病的临床和神经影像学综述。

Clinical and neuroimaging review of triplet repeat diseases.

机构信息

Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI, 48109, USA.

出版信息

Jpn J Radiol. 2023 Feb;41(2):115-130. doi: 10.1007/s11604-022-01343-5. Epub 2022 Sep 28.

DOI:10.1007/s11604-022-01343-5
PMID:36169768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9889482/
Abstract

Triplet repeat diseases (TRDs) refer to a group of diseases caused by three nucleotide repeats elongated beyond a pathologic threshold. TRDs are divided into the following four groups depending on the pathomechanisms, although the pathomechanisms of several diseases remain unelucidated: polyglutamine disorders, caused by a pathologic repeat expansion of CAG (coding the amino acid glutamine) located within the exon; loss-of-function repeat disorders, characterized by the common feature of a loss of function of the gene within which they occur; RNA gain-of-function disorders, involving the production of a toxic RNA species; and polyalanine disorders, caused by a pathologic repeat expansion of GCN (coding the amino acid alanine) located within the exon. Many of these TRDs manifest through neurologic symptoms; moreover, neuroimaging, especially brain magnetic resonance imaging, plays a pivotal role in the detection of abnormalities, differentiation, and management of TRDs. In this article, we reviewed the clinical and neuroimaging features of TRDs. An early diagnosis of TRDs through clinical and imaging approaches is important and may contribute to appropriate medical intervention for patients and their families.

摘要

三核苷酸重复疾病(TRD)是一组由三个核苷酸重复延伸超过病理阈值引起的疾病。TRD 可根据发病机制分为以下四组,尽管几种疾病的发病机制仍不清楚:多聚谷氨酰胺疾病,由位于外显子内的 CAG(编码氨基酸谷氨酰胺)病理性重复扩展引起;功能丧失重复疾病,其特征为发生在其中的基因的功能丧失的常见特征;RNA 获得功能疾病,涉及产生毒性 RNA 种类;和多丙氨酸疾病,由位于外显子内的 GCN(编码氨基酸丙氨酸)的病理性重复扩展引起。这些 TRD 中的许多通过神经症状表现出来;此外,神经影像学,特别是大脑磁共振成像,在 TRD 的异常检测、鉴别和管理中起着关键作用。在本文中,我们回顾了 TRD 的临床和神经影像学特征。通过临床和影像学方法早期诊断 TRD 很重要,可能有助于为患者及其家属提供适当的医疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/c8db6792853a/11604_2022_1343_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/1923e4b827dd/11604_2022_1343_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/4e4a1f3002f4/11604_2022_1343_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/84f313a25af4/11604_2022_1343_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/60491d6a826a/11604_2022_1343_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/1de50e4c725a/11604_2022_1343_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/b68b0845ed16/11604_2022_1343_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/f894a5c44562/11604_2022_1343_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/882ced30fa61/11604_2022_1343_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/37feb95df1c8/11604_2022_1343_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/81cfd68a1782/11604_2022_1343_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/93b5bf0f734b/11604_2022_1343_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/cfac5b221b4a/11604_2022_1343_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/4f1a2a95bdb7/11604_2022_1343_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/041b13700574/11604_2022_1343_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/38755b51113f/11604_2022_1343_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/b09369110220/11604_2022_1343_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/8baabd275f05/11604_2022_1343_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/ac99dccffecf/11604_2022_1343_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/c8db6792853a/11604_2022_1343_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/1923e4b827dd/11604_2022_1343_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/4e4a1f3002f4/11604_2022_1343_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/84f313a25af4/11604_2022_1343_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/60491d6a826a/11604_2022_1343_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/1de50e4c725a/11604_2022_1343_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/b68b0845ed16/11604_2022_1343_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/f894a5c44562/11604_2022_1343_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/882ced30fa61/11604_2022_1343_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/37feb95df1c8/11604_2022_1343_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/81cfd68a1782/11604_2022_1343_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/93b5bf0f734b/11604_2022_1343_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/cfac5b221b4a/11604_2022_1343_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/4f1a2a95bdb7/11604_2022_1343_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/041b13700574/11604_2022_1343_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/38755b51113f/11604_2022_1343_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/b09369110220/11604_2022_1343_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/8baabd275f05/11604_2022_1343_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/ac99dccffecf/11604_2022_1343_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9910/9889482/c8db6792853a/11604_2022_1343_Fig19_HTML.jpg

相似文献

1
Clinical and neuroimaging review of triplet repeat diseases.三重重复疾病的临床和神经影像学综述。
Jpn J Radiol. 2023 Feb;41(2):115-130. doi: 10.1007/s11604-022-01343-5. Epub 2022 Sep 28.
2
Triplet repeat expansion in neuromuscular disease.神经肌肉疾病中的三联体重复序列扩增
Muscle Nerve. 2000 Jun;23(6):843-50. doi: 10.1002/(sici)1097-4598(200006)23:6<843::aid-mus2>3.0.co;2-8.
3
CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders.CAG 重复 RNA 作为多聚谷氨酰胺疾病的辅助毒性剂。
RNA Biol. 2011 Jul-Aug;8(4):565-71. doi: 10.4161/rna.8.4.15397. Epub 2011 Jul 1.
4
Single amino acid and trinucleotide repeats: function and evolution.单氨基酸和三核苷酸重复:功能与进化。
Adv Exp Med Biol. 2012;769:26-40. doi: 10.1007/978-1-4614-5434-2_3.
5
Recent advances in molecular therapies for neurological disease: triplet repeat disorders.神经疾病分子治疗的最新进展:三核苷酸重复疾病。
Hum Mol Genet. 2019 Oct 1;28(R1):R80-R87. doi: 10.1093/hmg/ddz138.
6
[Advances in understanding of clinical presentations and molecular mechanisms of triplet repeat diseases].[三联体重复疾病临床表现及分子机制的认识进展]
Nihon Rinsho. 1999 Apr;57(4):778-86.
7
Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.肌强直性营养不良患者诱导多能干细胞中 CTG·CAG 三核苷酸重复序列扩增的长度依赖性。
Hum Mol Genet. 2013 Dec 20;22(25):5276-87. doi: 10.1093/hmg/ddt386. Epub 2013 Aug 9.
8
The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology.CAG多聚谷氨酰胺重复序列疾病:一种临床、分子、遗传和病理生理学分类学
Handb Clin Neurol. 2018;147:143-170. doi: 10.1016/B978-0-444-63233-3.00011-7.
9
Identification of trinucleotide repeat-containing genes in human pancreatic islets.人类胰岛中含三核苷酸重复序列基因的鉴定。
Diabetes. 1996 Feb;45(2):157-64. doi: 10.2337/diab.45.2.157.
10
Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.共济失调-3 蛋白修饰作为脊髓小脑共济失调 3 型的治疗策略:去除含有 CAG 的外显子。
Neurobiol Dis. 2013 Oct;58:49-56. doi: 10.1016/j.nbd.2013.04.019. Epub 2013 May 6.

引用本文的文献

1
Holoprosencephaly spectrum: an up-to-date overview of classification, genetics and neuroimaging.全前脑谱系:分类、遗传学及神经影像学的最新综述
Jpn J Radiol. 2025 Jan;43(1):13-31. doi: 10.1007/s11604-024-01655-8. Epub 2024 Sep 11.
2
Advances on the Mechanisms and Therapeutic Strategies in Non-coding CGG Repeat Expansion Diseases.非编码 CGG 重复扩展疾病的机制和治疗策略的进展。
Mol Neurobiol. 2024 Dec;61(12):10722-10735. doi: 10.1007/s12035-024-04239-9. Epub 2024 May 23.
3
Infantile-onset parkinsonism, dyskinesia, and developmental delay: do not forget polyglutamine defects!

本文引用的文献

1
Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia.小脑多系统萎缩与脊髓小脑共济失调的放射学鉴别要点。
Sci Rep. 2022 Jun 22;12(1):10499. doi: 10.1038/s41598-022-14531-0.
2
Clinical, Radiological, and Genetic Profile of Spinocerebellar Ataxia 12: A Hospital-Based Cohort Analysis.临床、放射学和遗传性小脑共济失调 12 型:基于医院的队列分析。
Tremor Other Hyperkinet Mov (N Y). 2022 Apr 21;12:13. doi: 10.5334/tohm.686. eCollection 2022.
3
Isolated Paravermal Hyperintensities in Neuronal Intranuclear Inclusion Disease.
婴儿期起病的帕金森病、运动障碍和发育迟缓:不要忘记多聚谷氨酰胺缺陷!
Ann Clin Transl Neurol. 2023 Oct;10(10):1937-1943. doi: 10.1002/acn3.51858. Epub 2023 Jul 25.
神经元核内包涵体病中的孤立性小脑蚓部旁高信号
Neurology. 2022 May 31;98(22):938-939. doi: 10.1212/WNL.0000000000200590. Epub 2022 Mar 29.
4
Quantitative susceptibility mapping reveals alterations of dentate nuclei in common types of degenerative cerebellar ataxias.定量磁化率图谱揭示常见类型退行性小脑共济失调中齿状核的改变。
Brain Commun. 2022 Jan 13;4(1):fcab306. doi: 10.1093/braincomms/fcab306. eCollection 2022.
5
Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease.揭示从临床前到临床期亨廷顿病结构磁共振成像变化的时间线。
Neurol Genet. 2021 Oct 12;7(5):e617. doi: 10.1212/NXG.0000000000000617. eCollection 2021 Oct.
6
FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report.通过皮肤活检,很难将 FXTAS 与神经核内包涵体病区分开来:一例报告。
BMC Neurol. 2021 Oct 12;21(1):396. doi: 10.1186/s12883-021-02425-z.
7
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group.弗里德里希共济失调的脑结构和退化分期:来自 ENIGMA-Ataxia 工作组的磁共振成像容积测量。
Ann Neurol. 2021 Oct;90(4):570-583. doi: 10.1002/ana.26200. Epub 2021 Sep 17.
8
Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case.神经元核内包涵体病合并肌萎缩侧索硬化症:一例尸检病例。
BMC Neurol. 2021 Jul 9;21(1):273. doi: 10.1186/s12883-021-02306-5.
9
Simultaneous Screening of the FRAXA and FRAXE Loci for Rapid Detection of FMR1 CGG and/or AFF2 CCG Repeat Expansions by Triplet-Primed PCR.三链引物 PCR 法快速检测 FMR1 CGG 和/或 AFF2 CCG 重复扩增:同时筛查 FRAXA 和 FRAXE 基因座
J Mol Diagn. 2021 Aug;23(8):941-951. doi: 10.1016/j.jmoldx.2021.04.015. Epub 2021 Jun 7.
10
Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers.1型脊髓小脑共济失调:一项为期一年的纵向研究,旨在确定患者和症状前携带者疾病进展的临床和MRI测量指标。
Cerebellum. 2022 Feb;21(1):133-144. doi: 10.1007/s12311-021-01285-0. Epub 2021 Jun 9.